N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Impact of Canine Mediation Practice in Psychomotor Therapy on Improving the Quality of Life in Adult Epileptic Patients.

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • ClinicalTrials.gov ID: NCT06898749

Registry updated: 2026-10-06
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

In addition to the search for new pharmaceutical or surgical solutions that could improve the therapeutic management of epileptic individuals, it is interesting to ask whether other complementary approaches, such as canine mediation in psychomotor therapy, could enhance the quality of life in this population. However, there is currently no evidence indicating that exposure to animals through mediation sessions would be beneficial for epileptic individuals, particularly regarding their quality of life, anxiety, emotional management, or cognition (such as social cognition). In the absence of current data in this population, it seems pertinent to study the impact of this practice on people with epilepsy. Furthermore, beyond quality of life, it would be valuable to examine whether it also influences anxiety or the frequency of seizures in individuals with epilepsy (a phenomenon reported for epileptic individuals living with a pet dog or a service dog). Canine mediation could help better manage and regulate the emotions of epileptic individuals, as well as improve their self-esteem.

Interventions

  • canine mediation (Other)
    Animal mediation consists of bringing an animal into contact with a specific audience to improve the mental or physical health of a person. The dog and beneficiaries interact through various activities, in which the animal participates, offered during the sessions. The dog plays a particularly important role as a mediator through the bonds it forms with the human, as well as a non-judgmental partner in interaction. The canine educator will be accompanied by a healthcare professional during interventions. The sessions are organized based on the expertise and suggestions of both professions (canine educator and psychomotor therapist). The canine educator will be a state-certified professional educator with a specialization in animal mediation. The dog used is trained by the educator, with two types of learning being worked on: emotions and "commands" on cue.
  • standard psychomotor therapy (Other)
    standard sessions of psychomotor therapy

Eligibility criteria

Inclusion Criteria: * Person aged ≥ 18 years * Presenting pharmacoresistant epilepsy according to the criteria of the International League Against Epilepsy * Requiring psychomotor therapy sessions for one of the following indications: Difficult emotional and relational management And/or global motor difficulties And/or body schema organization disorder And/or temporo-spatial disorder * Explicit consent or no opposition to participation in the study by the patient and/or their legal representative or guardian * Image rights consented by the patient and their legal representative or guardian, if applicable * Hospitalization or residence at the Teppe Institute or at the FAM (Foyer d'Accueil Médicalisé) des 4 Jardins planned for at least 3 months * Affiliated with or a beneficiary of a social security scheme Exclusion Criteria: * Fear or phobia of dogs * Epileptic person benefiting from a legal protection measure other than guardianship or curatorship * Person with insufficient cognitive abilities to respond to the questionnaires * Pregnant or breastfeeding woman

Conditions

Epilepsy

Locations

  • Fondation Partage et Vie - FAM Les Quatre Jardins — Saint-Étienne-de-Saint-Geoirs, France
  • Institut La Teppe — Tain-l'Hermitage, France
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record